Mandate

Vinge advises Alder II in conjunction with the acquisition of Scanacon

September 26, 2018 M&A

Alder II has entered into an agreement together with the management of the company to acquire the entire issued share capital of Scanacon Intressenter from the seller Verdane Capital.

Scanacon will be the first investment in Alder’s new fund, i.e. Alder II. Alder II is a Swedish based investment fund which invests in Nordic sustainable technology companies. The investments focus on established companies in the Nordic region.

Vinge’s team consisted of, among others, Johan Larsson, Albert Wållgren, Filip Brosset, Manne Bergström, Stina Bengtsson, Ludvig Wettergren and Andreas Lexhag which represented the purchaser Alder II in connection with the acquisition.  

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025